Kaijian Chu
Overview
Explore the profile of Kaijian Chu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chu K, Li Z, Tang W, Jiang X
Intractable Rare Dis Res
. 2022 Dec;
11(4):211-214.
PMID: 36457586
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare hepatic vascular tumor with a borderline biological behavior between hemangioma and hemangiosarcoma. It tends to be multiple or diffuse subcapsular lesions across the...
2.
Feng F, Gao Q, Wu Y, Liu C, Yu Y, Li B, et al.
Eur J Surg Oncol
. 2021 Jun;
47(9):2363-2368.
PMID: 34119376
Background: Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has survival benefits in patients with intraperitoneal malignant lesions, but there is no study specific to intrahepatic cholangiocarcinoma (ICC). Purpose:...
3.
Feng F, Cheng Q, Liu C, Wang H, Li B, Xu X, et al.
Hum Cell
. 2021 Apr;
34(3):918-931.
PMID: 33813726
Gallbladder carcinoma (GBC) is a lethal biliary tract malignant neoplasm. Patient-derived primary cancer cell lines (PDPCs) are appropriate models to explore biological characteristics and potential therapeutics; however, there is a...
4.
Li O, Li Z, Tang Q, Li Y, Yuan S, Shen Y, et al.
Med Sci Monit
. 2018 Nov;
24:8510-8523.
PMID: 30472720
BACKGROUND Long non-coding RNAs (lncRNAs) have been implicated in various human cancer types. However, the underlying mechanisms involved in hepatocellular carcinoma (HCC) progression remain poorly understood. MATERIAL AND METHODS In...
5.
Yuan L, Luo X, Lu X, Yi B, Chu K, Cai Q, et al.
Mol Clin Oncol
. 2017 Oct;
7(4):615-622.
PMID: 29046795
The effect of cirrhosis on the characteristics of intrahepatic cholangiocarcinoma (ICC) has not been fully elucidated. The purpose of this study was to investigate how cirrhosis affects the clinicopathological characteristics...
6.
Hang X, Wu Z, Chu K, Yu G, Peng H, Xin H, et al.
Tumour Biol
. 2016 Sep;
37(11):15079-15085.
PMID: 27658779
The aim of this study was to investigate the prognostic value of dicarbonyl/L-xylulose reductase (DCXR) in human hepatocellular carcinoma (HCC). Immunohistochemistry and tissue microarrays were used to evaluate DCXR protein...
7.
Hang X, Zhu S, Di H, Wu Z, Chu K, Wang J, et al.
Cell Physiol Biochem
. 2016 Jul;
39(2):768-79.
PMID: 27467187
Background/aims: Neural precursor cell-expressed developmentally down-regulated gene 4 (NEDD4) plays an important role in tumor cell growth, yet its role in hepatocellular carcinoma (HCC) remains unclear. This study is to...
8.
Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et al.
J Hepatol
. 2011 Sep;
56(2):389-96.
PMID: 21888875
Background & Aims: Portal vein tumor thrombus (PVTT) has previously been demonstrated to correlate with poor prognosis of hepatocellular carcinoma. Approximately 50-80% of HCC is accompanied by portal or hepatic...
9.
Fu X, Lu C, Chu K, Yao X, Cheng S, Gao C, et al.
J Surg Res
. 2009 Nov;
166(1):104-8.
PMID: 19922945
Background: Liver damage in hepatic surgery from warm ischemia and reperfusion (I/R), especially in patients with underlying chronic liver disease, is still challenging. We propose a new method of perfusion...